End-of-day quote
Shanghai S.E.
23:00:00 14/05/2024 BST
|
5-day change
|
1st Jan Change
|
7.18
CNY
|
+0.42%
|
|
-3.88%
|
-1.91%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,759
|
2,209
|
6,615
|
16,116
|
9,483
|
8,549
|
Enterprise Value (EV)
1 |
1,580
|
2,116
|
6,622
|
14,240
|
8,500
|
7,983
|
P/E ratio
|
491
x
|
-392
x
|
28.1
x
|
6.54
x
|
18.8
x
|
478
x
|
Yield
|
-
|
-
|
-
|
7.25%
|
2.46%
|
-
|
Capitalization / Revenue
|
3.71
x
|
3.74
x
|
1.74
x
|
2.01
x
|
1.32
x
|
1.59
x
|
EV / Revenue
|
3.33
x
|
3.58
x
|
1.74
x
|
1.78
x
|
1.19
x
|
1.48
x
|
EV / EBITDA
|
122
x
|
84.4
x
|
10.2
x
|
4.43
x
|
9.16
x
|
21.1
x
|
EV / FCF
|
-14.4
x
|
4.69
x
|
-14.1
x
|
10.4
x
|
55
x
|
-63.3
x
|
FCF Yield
|
-6.96%
|
21.3%
|
-7.08%
|
9.59%
|
1.82%
|
-1.58%
|
Price to Book
|
3.74
x
|
2.95
x
|
2.24
x
|
2.62
x
|
1.73
x
|
1.62
x
|
Nbr of stocks (in thousands)
|
306,421
|
306,421
|
1,048,348
|
1,167,843
|
1,167,843
|
1,167,843
|
Reference price
2 |
5.740
|
7.210
|
6.310
|
13.80
|
8.120
|
7.320
|
Announcement Date
|
18/04/19
|
28/04/20
|
23/04/21
|
14/03/22
|
07/04/23
|
15/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
474.3
|
590.5
|
3,795
|
8,004
|
7,172
|
5,390
|
EBITDA
1 |
12.91
|
25.08
|
648.8
|
3,214
|
928.2
|
379.1
|
EBIT
1 |
-3.707
|
-17.81
|
317.1
|
2,867
|
547.9
|
-13.5
|
Operating Margin
|
-0.78%
|
-3.02%
|
8.36%
|
35.82%
|
7.64%
|
-0.25%
|
Earnings before Tax (EBT)
1 |
4.235
|
-9.86
|
299.7
|
2,828
|
595.5
|
7.378
|
Net income
1 |
3.583
|
-5.637
|
231.3
|
2,402
|
505.1
|
17.91
|
Net margin
|
0.76%
|
-0.95%
|
6.09%
|
30.01%
|
7.04%
|
0.33%
|
EPS
2 |
0.0117
|
-0.0184
|
0.2242
|
2.111
|
0.4325
|
0.0153
|
Free Cash Flow
1 |
-109.9
|
451.5
|
-468.8
|
1,366
|
154.6
|
-126.2
|
FCF margin
|
-23.18%
|
76.46%
|
-12.35%
|
17.06%
|
2.16%
|
-2.34%
|
FCF Conversion (EBITDA)
|
-
|
1,800.01%
|
-
|
42.5%
|
16.66%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
56.85%
|
30.61%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
1.000
|
0.2000
|
-
|
Announcement Date
|
18/04/19
|
28/04/20
|
23/04/21
|
14/03/22
|
07/04/23
|
15/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
7.19
|
-
|
-
|
-
|
Net Cash position
1 |
179
|
92.8
|
-
|
1,876
|
983
|
566
|
Leverage (Debt/EBITDA)
|
-
|
-
|
0.0111
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
-110
|
452
|
-469
|
1,366
|
155
|
-126
|
ROE (net income / shareholders' equity)
|
0.74%
|
-0.39%
|
8.59%
|
52.8%
|
8.69%
|
0.33%
|
ROA (Net income/ Total Assets)
|
-0.39%
|
-0.54%
|
5.55%
|
33.6%
|
5.15%
|
-0.13%
|
Assets
1 |
-912.5
|
1,040
|
4,168
|
7,146
|
9,804
|
-13,463
|
Book Value Per Share
2 |
1.530
|
2.440
|
2.810
|
5.260
|
4.690
|
4.510
|
Cash Flow per Share
2 |
0.2500
|
0.1500
|
0.1800
|
1.430
|
0.8200
|
0.7700
|
Capex
1 |
8.18
|
50.1
|
381
|
470
|
554
|
847
|
Capex / Sales
|
1.72%
|
8.48%
|
10.03%
|
5.88%
|
7.72%
|
15.71%
|
Announcement Date
|
18/04/19
|
28/04/20
|
23/04/21
|
14/03/22
|
07/04/23
|
15/04/24
|
|
1st Jan change
|
Capi.
|
---|
| -1.91% | 1.15B | | +5.62% | 106B | | -3.11% | 63.67B | | +73.81% | 49.32B | | +15.46% | 38.56B | | +5.54% | 32.65B | | +11.56% | 20.08B | | +13.74% | 17.01B | | +20.05% | 15.41B | | +5.02% | 14.41B |
Other Commodity Chemicals
|